Log-in / Create Account  
 
DIA 2013 49th Annual Meeting
Click here to go to the previous page
Implementation of Quality by Design: Progress, Challenges and Opportunities - Industry Perspective
Track : Track 12: Pharmaceutical Quality
Program Code: 354
Date: Wednesday, June 26, 2013
Time: 1:45 PM to 3:15 PM  EST
Location: 153C
CHAIR :
 Moheb M. Nasr, PhD,MS (SCHNON), Vice President, Regulatory CMC Strategy, GlaxoSmithKline, United States
SPEAKER (S):
 Michael Thien, DrSc (SPKNON), Senior Vice President, Global Science, Technology and Commercialization, Merck & Co., Inc., United States
 Patricia N. Hurter, PhD,MS (SPKNON), Senior Vice President, Product Development, Vertex Pharmaceuticals, United States
 Lynne Krummen, (SPKNON), Vice President, Technical Regulatory, Biologics, Genentech, A Member of the Roche Group, United States
Description
Three industry speakers, representing different segments of the pharma industry, will share their perspectives on Quality by Design (QbD) implementation progress. Presentations will outline different implementation approaches supplemented by case studies.

Session Recording
(Code: 354)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Handout Online
(Code: 354)
DIA 2013 Attendee:
Attendees Login
  
This session is a part of:
DIA 2013 Live Learning Center
CON4 Comp Access: Wednesday Online Access Package - June 26, 2013
Implementation of Quality by Design: Progress, Challenges and Opportunities - Industry Perspective